Alpine Associates Management’s Dynavax Technologies DVAX Stock Holding History

Alpine Associates Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-475,000	Closed	-$7.31M	–	81
2025 Q4	$7.31M	Buy	+475,000	New	+$5.23M	0.49%	46

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alpine Associates Management's DVAX Position: Q1 2026 in Review

Alpine Associates Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 475,000 shares — an estimated $7.31M sold.

Alpine Associates Management first reported a position in DVAX in Q4 2025 and held it in 1 quarter. The position peaked at $7.31M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Alpine Associates Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Alpine Associates Management sold 475,000 Dynavax Technologies shares in Q1 2026, an estimated $7.31M.
Alpine Associates Management first reported a position in Dynavax Technologies in Q4 2025 and held it in 1 quarter.
Alpine Associates Management's Dynavax Technologies position peaked at $7.31M in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Alpine Associates Management's 13F filing for Q1 2026, filed 21 Apr 2026.